Global University Venturing

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

EPFL-backed Foundation for Technology Innovation has appointed David Kappeler as director and head of investments.

Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.

Woodford Investment Management has had nothing but bad luck for months and there is a looming question as to whether the firm can survive.

Quentin Compton-Bishop has resigned as CEO of Warwick Ventures, but said he would continue to be involved in university venturing.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

Notion Capital Venture Capital IV has added Texas A&M University to its limited partners as it seeks a $150m final close.

Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.

GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.